đ° Future Outlook News
Future Outlook News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Future Outlook. Real-time updates on events, politics, business and more.
May 29, 2024
K2 Infragen Limited, a leading infrastructure EPC company, reported significant growth in FY24, with revenue up by 63.3%, and is planning international expansion in Africa and the Middle East. The company also aims to secure Rs 800 Crore in new orders for FY24-25. Strong performance aligns with their machinery-based model and government project collaborations.
May 23, 2024
CARGOTEC CORPORATION, STOCK EXCHANGE RELEASE, 23 MAY 2024 AT 1:30 PM Correction: The Finnish Financial Supervisory Authority has approved the prospectus concerning the partial demerger of...
May 23, 2024
CARGOTEC CORPORATION, STOCK EXCHANGE RELEASE, 23 MAY 2024 AT 1:30 PM (EEST) Cargotec Corporation ("Cargotec") announced on 1 February 2024 the approval of a demerger plan concerning the partial demerger
May 23, 2024
Investegate announcements from Correction: The Finnish Financial Supervisory Authority has approved the prospectus concerning the partial demerger of Cargotec and listing of Kalmar
May 22, 2024
CARGOTEC CORPORATION, STOCK EXCHANGE RELEASE, 22 MAY 2024 AT 2:30 P.M. The Finnish Financial Supervisory Authority has approved the prospectus concerning the partial demerger of Cargotec and...
May 22, 2024
Investegate announcements from The Finnish Financial Supervisory Authority has approved the prospectus concerning the partial demerger of Cargotec and listing of Kalmar
May 22, 2024
CARGOTEC CORPORATION, STOCK EXCHANGE RELEASE, 22 MAY 2024 AT 2:30 P.M. (EEST) The Finnish Financial Supervisory Authority has approved the prospectus concerning the partial demerger of Cargotec and
May 21, 2024
Spokesperson Name: Daniel Yu Title: Assistant Vice President Tel: 02-27193333 ...
May 21, 2024
While AI offers compelling benefits, implementing it effectively requires a well-defined cybersecurity strategy.
May 3, 2024
The panelists provide their perspective on best practices for keeping up with the rapidly evolving RET fusion landscape and unmet needs to be addressed by future RET-targeted therapies beyond lung cancer.